Huanxin Lin

6PUBLICATIONS
26CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
The PDGFB-DDX5 axis contributes to breast cancer radioresistance through HR-associated DNA repair.

|Jan 30, 2025
Identification and validation of a prognostic signature of drug resistance and mitochondrial energy metabolism-related differentially expressed genes for breast cancer.

Tiankai Xu, Chu Chu, Shuyu Xue

|May 28, 2024
Significance of Pre-Treatment CALLY Score Combined with EBV-DNA Levels for Prognostication in Non-Metastatic Nasopharyngeal Cancer Patients: A Clinical Perspective.

Tongchao Jiang, Haishuang Sun, Tiankai Xu

|Apr 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Ying Chen, Wen-Xia Li, Jia-Hua Wu

|Aug 19, 2022
M1 stage subdivisions based on 18F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.

Hui-Zhi Qiu, Xu Zhang, Sai-Lan Liu

|Mar 09, 2021
A prognostic survival model based on metabolism-related gene expression in plasma cell myeloma.

Han-Ying Huang, Yun Wang, Wei-da Wang

Pageof 1

Frequent Collaborators

2 joint publications

Zhenyu He

1 joint publications

Han-Ying Huang

1 joint publications

Wei-da Wang

1 joint publications

Juan Li